LMNGF News and Press, BioVaxys Technology From 05/03/21

BioVaxys And BioElpida Sign Definitive Exclusive Agreement To Begin Ovarian Cancer Vaccine Bioproduction Canada NewsWire VANCOUVER, BC , May 3, 2021 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (CSE: BIOV.CN) (FRA: 5LB) (OTC: BVAXF ) ( "BioVaxys" or...

BioVaxys Broadens Intellectual Property Portfolio Commercial Trademark Application Filed for CoviDTH® Diagnostic Commercial trademark application FILED for CoviDTH® diagnostic cancer vaccine platform patent coverage expanded to NOW include over 12 tumor types PR Ne...

BioVaxys Assigned "BVAXF" By Finra As New US OTC Trading Symbol Canada NewsWire VANCOUVER, BC and TORONTO , April 21, 2021 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA:5LB) (OTC:BVAXF) ( "BioVaxys"), the world leader in haptenized antigen...

Biovaxys And The World Ovarian Cancer Coalition Join Forces For May 8th, World Ovarian Cancer Day Canada NewsWire VANCOUVER, BC and TORONTO , April 20, 2021 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ( "BioVaxys"), the world le...

BioVaxys Announces Final Clinical trial results of HPV product from EU partner ProCare Health Iberia published by American Society for Colposcopy and Cervical Pathology - Papilocare® demonstrates efficacy of in healing cervical lesions 6 months after treatment in 88% of pat...

FN Media Group Presents USA News Group News Commentary Vancouver, BC – March 31, 2021 – USA News Group –  As regulators in differing markets around the world continue to work on plans surrounding Covid-19 that will either open up their markets o...

BIOVAXYS files FDA pre-IND meeting request and briefing package for COVID-T Canada NewsWire VANCOUVER, BC , March 31, 2021 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA:5LB) (OTC:LMNGF) ( "BioVaxys"), the world leader in haptenized antigen vaccines...

FN Media Group Presents USA News Group News Commentary Vancouver, BC – March 25, 2021 – USA News Group –  Rollouts of two approved COVID-19 vaccines have for the past few months started making their way into markets around the world. Amid the at...

Palm Beach, FL – March 24, 2021 – While the world has reason to become optimistic about seeing a light at the end of the tunnel, due to the development of vaccines to fight and rein in the current global pandemic, more concerns arise if the current vaccines will also tame the ...

BioVaxys Expands Intellectual Property Portfolio Canada NewsWire - Patent Filing To Address Emerging SARS-CoV-2 Variants - National Phase Filings For Cancer Vaccine VANCOUVER, BC , March 24, 2021 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) ...